Nov 13, 2020 / 08:30PM GMT
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Good afternoon, everybody, and thank you once again for joining us for the Fourth Annual IO Summary that coincides with the SITC conference. I'm Yaron Werber, Biotech Analyst here at Cowen. And it's a great pleasure to moderate the last session of the day with Amgen. We have 2 gentlemen that really need no introduction. David Reese is Chief Medical Officer; and Arvind Sood is VP of Investor Relations. Gentlemen, thanks so much for joining us. We appreciate it.
David M. Reese - Amgen Inc. - EVP of Research & Development
Thank you, Yaron. And just for clarity, I'm Head of R&D, not, in fact, our Chief Medical Officer.
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
That is correct. I've been so used to saying Chief Medical Officer all day today, I apologize.
David M. Reese - Amgen Inc. - EVP of Research & Development<
Amgen Inc at Cowen Immuno-Oncology Next Summit Transcript
Nov 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers